Vascular & Endovascular: A new imaging technique for blood vessels | AAA EVAR recommendations | Treating PVT

News You Need to Know Today

Wednesday, March 23, 2022

Editor's Choice: Vascular & Endovascular

New-look imaging technique could change the way we see blood vessels

The new method, still being tested with mouse models, could help clinicians see blood vessels with improved clarity.

The new imaging method VascuViz includes a quick-setting polymer mixture to fill blood vessels and make them visible in multiple imaging techniques. It enables visualization of the structure of a tissue’s vasculature, which in conjunction with detailed mathematical models or complementary images of other tissue elements can clarify the complex role of blood flow in health and disease. Watch a video example of this technology

New-look imaging technique could change the way we see blood vessels

The new method, still being tested with mouse models, could help clinicians see blood vessels with improved clarity.

FDA Roundup: AAA EVAR recommendations, key approvals in stroke care and interventional cardiology

The FDA has been busy, sharing recommendations and clearing solutions that could have a significant impact on cardiovascular care throughout the United States.

Examples of CT imaging showing aortic dissections on an acute AAA response team app that was recently cleared by the FDA from Viz.AI.

FDA Roundup: AAA EVAR recommendations, key approvals in stroke care and interventional cardiology

The FDA has been busy, sharing recommendations and clearing solutions that could have a significant impact on cardiovascular care throughout the United States.

Evolocumab limits adverse cardiovascular outcomes among PCI patients

Data from the FOURIER trial helped clinicians learn more about this popular PCSK9 inhibitor.

Evolocumab limits adverse cardiovascular outcomes among PCI patients

Evolocumab limits adverse cardiovascular outcomes among PCI patients

Data from the FOURIER trial helped clinicians learn more about this popular PCSK9 inhibitor.

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief.

PCI can improve the odds of survival for some ischemic heart failure patients with moderate-to-severe functional mitral regurgitation, according to a new study. Image courtesy of Beaumont Hospital. Interventional cardiology procedure in a cath lab at Beaumont Hospital.

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief.

Thrombolysis vs. surgery for prosthetic valve thrombosis

The three-month mortality rate was 2.4% after thrombolysis and 18.7% after surgery.

Examples of prosthetic heart valve thrombus formation on the valve leaflets. A new study shows better outcomes using tPA vs. surgery to remove the clots. Valve thrombosis. Images from Mayo Clinic

Thrombolysis vs. surgery for prosthetic valve thrombosis

The three-month mortality rate was 2.4% after thrombolysis and 18.7% after surgery.

DOACs may reduce the risk of dementia among AFib patients by 50%

Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis.

DOACs may reduce the risk of dementia among AFib patients by 50%

Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis.

Distal radial access consistently lowers risk of artery occlusion during PCI

The new meta-analysis, published in the American Journal of Cardiology, includes data from 16 different studies.

While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.

Distal radial access consistently lowers risk of artery occlusion during PCI

The new meta-analysis, published in the American Journal of Cardiology, includes data from 16 different studies.

Researchers review PCI outcomes, find little evidence of a ‘July effect’ in interventional cardiology

New trainees may not necessarily lead to a higher risk of medical errors during PCI.

Cardiac cath lab at the University of California San Diego Health System in La Jolla.

Researchers review PCI outcomes, find little evidence of a ‘July effect’ in interventional cardiology

New trainees may not necessarily lead to a higher risk of medical errors during PCI.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

Editor's Choice: Vascular & Endovascular

Recent Newsletters